CBLB and neoplasm: A deficiency of TCR signaling 1(STS1) or casitas B lymphoma-b (Cbl-b) can promote T cell proliferation and differentiation activity in vivo, inhibit tumor growth, prolong survival, and improve T cell fitness in tumor models [119].